SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP
Delisted
SLXP was delisted on the 31st of March, 2015.
348 hedge funds and large institutions have $10.6B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 102 increasing their positions, 146 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
27% less call options, than puts
Call options by funds: $346M | Put options by funds: $477M
30% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 146
Holders
348
Holding in Top 10
19
Calls
$346M
Puts
$477M
Top Buyers
| 1 | +$312M | |
| 2 | +$142M | |
| 3 | +$117M | |
| 4 |
SC
Sculptor Capital
New York
|
+$97.8M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$93.4M |
Top Sellers
| 1 | -$232M | |
| 2 | -$198M | |
| 3 | -$155M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$116M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$109M |